| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 2.227 | 3.318 | 1.160 | 4.130 | 746 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 2.227 | 3.318 | 1.160 | 4.130 | 746 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 4 | 1.441 | 2.012 | 3.678 | 1.190 | 440 | 426 | 398 | 386 |
| Gross Profit/Loss - EUR | 0 | 2.222 | 1.877 | -852 | 452 | -444 | -440 | -426 | -398 | -386 |
| Net Profit/Loss - EUR | 0 | 2.156 | 1.777 | -887 | 328 | -466 | -440 | -426 | -398 | -386 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Msp Nutrimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 2.411 | 2.107 | 2.995 | 2.418 | 2.058 | 1.588 | 1.166 | 765 | 374 |
| Current Assets | 45 | 2.555 | 2.154 | 640 | 1.987 | 1.294 | 1.251 | 611 | 609 | 606 |
| Inventories | 0 | 283 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 2.227 | 207 | -290 | -85 | 16 | 15 | 15 | 15 | 15 |
| Cash | 45 | 45 | 1.947 | 929 | 2.071 | 1.279 | 1.236 | 596 | 594 | 591 |
| Shareholders Funds | 45 | 2.200 | 3.940 | 2.981 | 3.251 | 2.724 | 1.548 | 1.126 | 725 | 335 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 2.765 | 321 | 653 | 1.153 | 629 | 1.291 | 651 | 649 | 646 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Msp Nutrimed Srl